Literature DB >> 10092881

Molecular cloning, cell localization and binding affinity to DNA replication proteins of the p36/LACK protective antigen from Leishmania infantum.

G Gonzalez-Aseguinolaza1, S Taladriz, A Marquet, V Larraga.   

Abstract

The p36/LACK antigen from Leishmania, an analogue of the receptor for activated protein kinase C (PKC), induces high levels of protection against parasite infection in the BALB/c mouse model. This protection is more than twice as high as that elicited by major parasite antigens such as soluble Leishmania antigen or the main surface protease gp63. We have cloned and purified p36/LACK from Leishmania infantum, the causative agent of visceral leishmaniasis in Europe. This protein belongs to the large family of WD 40 repeat proteins confined to eukaryotes and involved in numerous regulatory functions. Differential solubilization and immunofluorescence experiments indicate that p36/LACK is present close to the kinetoplast disc in the cell cytoplasm, probably bound to multiprotein complexes but not to membrane structures. These complexes probably also include cytoplasm PKC isoforms. The use of a genetically-encoded peptide library indicates that p36/LACK binds sequences present in several proteins involved in DNA replication and RNA synthesis. The recognition and binding sequences present in vacuolar proteins and at the beta-chain of major histocompatability complex (MHC) class II suggest the involvement of this regulatory protein in the early mechanisms triggering the protective immune response of the host against the parasite infection.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10092881     DOI: 10.1046/j.1432-1327.1999.00122.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  19 in total

1.  Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation.

Authors:  Nir Qvit; Opher S Kornfeld
Journal:  J Vis Exp       Date:  2016-01-26       Impact factor: 1.355

2.  Listeria monocytogenes as a short-lived delivery system for the induction of type 1 cell-mediated immunity against the p36/LACK antigen of Leishmania major.

Authors:  N Soussi; G Milon; J H Colle; E Mougneau; N Glaichenhaus; P L Goossens
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

3.  Receptor for activated C kinase ortholog of second-generation merozoite in Eimeria tenella: clone, characterization, and diclazuril-induced mRNA expression.

Authors:  Bian-hua Zhou; Xiao-jiong Shen; Hong-wei Wang; Tao Li; Fei-qun Xue
Journal:  Parasitol Res       Date:  2012-06-30       Impact factor: 2.289

4.  Proteomic approach for characterization of immunodominant membrane-associated 30- to 36-kiloDalton fraction antigens of Leishmania infantum promastigotes, reacting with sera from Mediterranean visceral leishmaniasis patients.

Authors:  Sayda Kamoun-Essghaier; Ikram Guizani; Jean Marc Strub; Alain Van Dorsselaer; Kamel Mabrouk; Lazhar Ouelhazi; Koussay Dellagi
Journal:  Clin Diagn Lab Immunol       Date:  2005-02

5.  Intradermal NKT cell activation during DNA priming in heterologous prime-boost vaccination enhances T cell responses and protection against Leishmania.

Authors:  Blaise Dondji; Eszter Deak; Karen Goldsmith-Pestana; Eva Perez-Jimenez; Mariano Esteban; Sachiko Miyake; Takashi Yamamura; Diane McMahon-Pratt
Journal:  Eur J Immunol       Date:  2008-03       Impact factor: 5.532

6.  Intranasal vaccination against cutaneous leishmaniasis with a particulated leishmanial antigen or DNA encoding LACK.

Authors:  Eduardo Fonseca Pinto; Roberta Olmo Pinheiro; Alice Rayol; Vicente Larraga; Bartira Rossi-Bergmann
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

7.  Comparative evaluation of two vaccine candidates against experimental leishmaniasis due to Leishmania major infection in four inbred mouse strains.

Authors:  Fouad Benhnini; Mehdi Chenik; Dhafer Laouini; Hechmi Louzir; Pierre André Cazenave; Koussay Dellagi
Journal:  Clin Vaccine Immunol       Date:  2009-09-02

8.  Cloning, functional analysis and post-transcriptional regulation of a type II DNA topoisomerase from Leishmania infantum. A new potential target for anti-parasite drugs.

Authors:  Tobias Hanke; María J Ramiro; Sonia Trigueros; Joaquim Roca; Vicente Larraga
Journal:  Nucleic Acids Res       Date:  2003-08-15       Impact factor: 16.971

9.  High quality long-term CD4+ and CD8+ effector memory populations stimulated by DNA-LACK/MVA-LACK regimen in Leishmania major BALB/c model of infection.

Authors:  Lucas Sánchez-Sampedro; Carmen Elena Gómez; Ernesto Mejías-Pérez; Carlos Oscar S Sorzano; Mariano Esteban
Journal:  PLoS One       Date:  2012-06-08       Impact factor: 3.240

10.  Phylogenetic and evolutionary analysis of Chinese Leishmania isolates based on multilocus sequence typing.

Authors:  Chun-Ying Zhang; Xiao-Jun Lu; Xiao-Qing Du; Jun Jian; Ling Shu; Ying Ma
Journal:  PLoS One       Date:  2013-04-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.